Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Some goober (probably goobers) discovered that you can add to the board view count by just refreshing the page. And you don't even have to be a board member to do it.
Even funnier is that you find that statistic meaningful.
There's no mention of it on the docket.
I don't know what "Review Appeals Filed" means.
When the item first appeared on the docket in April it said:
"Review Appeals Filed 03/11/2024 05/08/2024"
I believe that that was the basis for olden_grumpini's comment
Now it says:
"Review Appeals Filed 03/11/2024 06/12/2024"
IPIX filed a Notice of Appeal on 3/7 but that's just a statement of intent. An actual Appeal is a comprehensive filing providing a detailed basis.
I think.
o_g? Any thoughts?
"Sure is a lot of views for a "dead company". 😁
How can this be?"
It's nonsense, obviously.
Have you appealed to your broker Fidelity based on "accredited investor" status?
"The SEC defines an accredited investor as someone who meets one of the following three requirements:
Has an individual income of more than $200,000 per year, or a joint income of $300,000, in each of the last two years and expects to reasonably maintain the same level of income.
Has a net worth exceeding $1 million, either individually or jointly with his or her spouse.
Is a general partner, executive officer, director or a related combination thereof for the issuer of a security being offered."
https://www.bing.com/search?form=MOZLBR&pc=MOZR&q=%22accredited+investor%22+definition
Still trying to help in spite of your occasional insult. I figure if anyone deserves to own more shares of IPIX it's you.
Next come the Herpes, Human Papillomavirus (HPV), HIV, Hendra and Nipah Viruses, Ebola, Marburg and sniffles PRs....and who can forget dengue!
Wonder if they'll raise that good old drug design in the field capability?
Uncle Miltie must be bummed that he's missing out.
per Schwab:
""Starting on May 28, 2024, the settlement period for most securities traded on U.S. exchanges or over the counter will shorten from two business days (T+2) to one business day (T+1)."
Without any trading that's not gonna matter much.
Are these investors still here?
"At one point one of the biggest knocks on NNVC was that "they would never be able to scale up production" sufficiently. They appear to have gotten over that hump now."
Is there something in particular that makes it appear that way to you?
"For a security to become worthless, it not only needs to have no value, but it needs to have no potential to regain value."
That's a fine theory regarding value but if you hope to recognize value in the price of the stock you need buyers and even those who are willing to buy have been met at the door of their brokerages by a sign saying "no buy orders accepted".
How do you propose that the Company will overcome that problem?
It was 100% correct when it was written. This message, which appears in the IPIX trading session now when a buy order is attempted, did NOT appear when I said they would take your order:
Hey! Long time no see. Your last appearance had you asking "Is trading halted?" on a day that 125million shares were traded. People with IPIX shares at the close of trading that day held them at $.0892, about 42 times what they go for today.
Don't be such a stranger!
"Thank you for this Schwab information. If it is true and I can buy I will make a new account."
Did you find it to be true? (I don't care if you made a new account.)
And what happened to this?
Nothing.
I don't have either notation but they look like footnotes. Are 3 and 4 described further down the page?
What page are you looking at? My Schwab account doesn't have that notation on the Position page....phone or computer.
ABSSSI - In February 2016, the Company submitted a Special Protocol Assessment (SPA) request, along with a final protocol, to the FDA, for a Phase 3 clinical trial of Brilacidin for the treatment of Acute Bacterial Skin and Skin Structure Infection (ABSSSI) caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA). We received from the FDA comments and considerations for incorporation into our study design. Management decided to delay its response to the FDA due to the low price per share of our common stock and the many multiple million dollar costs associated with a Phase 3 program. Our strategy, for now, is to achieve success with other trials and attract partnering opportunities that may provide significant upfront payments and milestone payments, which can then be used to fund the ABSSSI program. We see ABSSSI as the appropriate gateway indication in infectious diseases, enabling potential further studies of Brilacidin’s use for implant coating and biofilm infections.
https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223007158/ipix_10k.htm (2023 10-K)
Warning! This security is traded on the Expert Market
The Expert Market® serves broker-dealer pricing and investor best execution needs. Quotations in Expert Market securities are restricted from public viewing. OTC Markets Group may designate securities for quoting on the Expert Market when it is not able to confirm that the company is making current information publicly available under SEC Rule 15c2-11, or when the security is otherwise restricted from public quoting.
https://www.otcmarkets.com/stock/IPIX/overview (today)
The same results could have been achieved if the candidate tested was corn flakes.
Go to the original article.
There are two tables labeled Table 1 Brilacidin activity against problem pathogens and Table 2 Initial screen of Brilacidin activity against other problem pathogens. All you need to see them is click on the boxes with the arrows.
I haven't studied them too closely but those SEEM to be the only things that you missed. They make themselves apparent when you click the download button, as suggested.
It is free, but you only posted part of the article. Press the Download button.
"Has anyone popped the $26 or so bucks for a copy of the article?"
Why do that when you can download it from the linked page?
Bullshit. Never happened.
No need to guess:
"Brilacidin (N4, N6-bis(3-(5-gaunidinopentanamido)-2-(R)-pyrrolidin-3-yl)oxy)-5-(trifluoromethyl)phenyl)pyrimidine-4,6-dicarboxamide tetrahydrochloride) (C40H50F6N14O6.4HCl), MW 1082.7, sterile and >98% pure, was supplied by Innovation Pharmaceuticals, Wakefield, MA, USA. It was supplied as a solid and was readily soluble in water and liquid media, such as RPMI-1640. To convert µg/mL, as expressed in this paper, to millimolar, multiply µg/mL by 0.924. "
Would they call that "funding"?
You're wrong about this. Learn the difference between IHub administrators and Board moderators....it's significant.
I did the following, using 3M shares @$.002, before I said that Schwab might be able to help...I had no reason to mislead you:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=174252754
Obviously I cancelled the trade before it executed. One issue you might run into is their policy regarding the taking of a NEW IPIX position with them. I have 100 shares in one of my accounts so the 3M order would not have been a new position. Different brokers handle Expert Market orders differently and I've heard that some won't take a NEW position.
You might want to call before applying for a new account in case they aren't taking new opening orders.
Place your order with Schwab. They'll take it. No idea whether your $.002 limit offer will get filled though.
It's just my opinion, of course, but anyone who would buy shares in a Company with a CEO who has dropped out of sight isn't being very smart.
"I own Brilacidin and some BeaMed."
At this point you can't be sure of that (https://www.sec.gov/cgi-bin/browse-edgar?company=innovation+pharmaceuticals) and even if you could there's no hard evidence to show that they are worth owning. Even before this latest slip into the abyss of the Expert Market investors as a group couldn't move this thing past two cents.
I'm not obsessed with Leo but his actions and failures to act of late have been hard to ignore.
"Company leaders can be replaced.
Any person in a company can be replace."
Idle chatter.
How would you suggest that that could be done exactly?
"This article is a preprint and has not been certified by peer review"
But let's say that it was. Who's gonna run the trial?
"Back in the day I accused you of beating and beating and beating the Dead horse."
But I was right about the horse. And now you're admitting that it was dead.
"Maybe the Sec/finra will investigate you and your Cabal."
Nonsense. The truth is a very strong defense and we're all entitled to our opinions. Even you.
Here's the truth as of 4:00PM Eastern yesterday:
IPIX
Innovation Pharmaceuticals Inc (CE) (IPIX) Quote
0.003
(note: the CE designation is a copy and paste from https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-ce-IPIX/stock-price )
You can lay the blame for THAT truth at the doorstep of those who have been wrong for the last dozen years or so.
http://www.ipharminc.com/senior-management
http://www.ipharminc.com/board-of-directors
Don't blame me.
Same questions:
Where's Leo?
"The Brazil team is busy."
"The Israel team remain in schedule to ask USA FDA early June for approvals to sell their new system."
You make things sound good. Seems an odd time for a CEO to disappear without a trace, doesn't it?
What will it take for you to stop dispensing hope where none is warranted?
"Today for the first time in well over a year I got some useful data from this website."
Not from IPIX you didn't....a lack of current information explains their $.00X share price and their appearance on the inaptly called "Expert Market".
And today for the first time in over a year you saw fit to comment. Did you not see the passing on of Kevetrin and the IPIX cash balance as useful data worthy of comment?
Just a suggestion.
"For now the price and trade of Ipix sleeps."
https://www.facebook.com/MontyPython/videos/monty-python-dead-parrot/1041033669786167/
Where's Leo?
"The Brazil team is busy."
"The Israel team remain in schedule to ask USA FDA early June for approvals to sell their new system."
You make things sound good. Seems an odd time for a CEO to disappear without a trace, doesn't it?
What will it take for you to stop dispensing hope where none is warranted?
"Could have sworn Barry Schechter and Zorik Spektor were both removed from the page."
They weren't. You're not suggesting that they are still on the Board, are you?
Do you think Leo Ehrlich is still CEO?
Could you have sworn that he was removed from the page as well? There hasn't been a filing reporting his resignation.
http://www.ipharminc.com/board-of-directors
" ever question why 200k shares were just purchased?"
I figured you or one of the other loyalists stumbled over $460 in nickels in your couch cushions.
That size buy doesn't exactly scream "accredited investor".
"and now she is gone."
It LOOKS that way, but this cloak of silence that LE has donned leaves us guessing.
She (and he) could be continuing to collect their regular checks and just erasing their public connections to IPIX.
Did LE leave the Company checkbook behind?
Jane Harness
Company name has been changed....in this case deleted....to try to protect a badly soiled reputation.
Guess she learned the benefits of scrubbing from her mentor.
Experience
Clinical Research & Project Management Consultant
2016 - Present · 8 yrs 4 mos
MA, USA
Vice President, Clinical OperationsVice President, Clinical Operations
Revance Therapeutics, Inc.Revance Therapeutics, Inc.
2014 - 2015 · 1 yr2014 - 2015 · 1 yr
Newark, CA, USANewark, CA, USA
Head of Clinical Sciences, Dermatology & ATI Translational Research
Novartis Institutes for BioMedical ResearchNovartis Institutes for BioMedical Research
2010 - 2014 · 4 yrs
Basel, SwitzerlandBasel, Switzerland
Clinical Lead/ Director
Pfizer
2002 - 2010 · 8 yrs
Led the overall clinical development of multiple Dermatology programs, oral and topical.Led the overall clinical development of multiple Dermatology programs, oral and topical.…see more
Note "2016 - Present"
Somebody bought em and somebody sold em, no?
More likely someone decided to take their $4-5k and go home.
Probably a smart move.
fb?
"Leo told us about the BoD leaving but nothing on Jane and the last hire? Strange"
Are you serious? Leo didn't even tell us about Leo.
The Director resignations required a filing and that happened on 2/1. Jane's situation does not.
Leo didn't file the 10Q or the Lateness Notification which was due on 2/15.
If Leo resigned any of his positions he was obligated to submit a filing saying so but he has done the most irresponsible thing he could possibly do.....disappear without a peep.
Frenchbroad is still around and reading the board. Speechless I guess....I know that I would be.
https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-ce-IPIX/stock-price
Obviously I can only answer for myself:
Do you really think that a judgment against the Company for more cash than it has, the resignation of both independent Directors, the relegation of the Company's shares to the Expert Market making them barely tradable and the literal disappearance of the CEO makes IPIX LESS interesting? Because it doesn't. And I'd like to see how those things play out.
For me the risk of hanging around is negligible.
I believe the Ignore feature is still functional. If the truth hurts you might want to use it.
By the way, regarding "if it's game over like you say it is" I never said that it was, but there aren't too many good reasons to think that it isn't.